Our experienced and dedicated injury law firm is based in Atlanta, GA and has special experience in representing those who have lost loved ones and fallen ill because of Zantac consumption. It is our intention to bring these drug companies to terms with those who have suffered from their choice to place profits above human health and conceal the Zantac cancer link. If you have been harmed from consumption of this drug contact an Atlanta Zantac lawyer today at Schneider Hammers.
The US FDA (Food and Drug Administration) has recently completed testing of over 150 Zantac tablets and found that this commonly used as an OTC heartburn medication also contains a carcinogenic constituent in amounts equal to 3,000 times the FDA’s recommended daily consumption limit. The carcinogenic compound in Zantac is called N-nitrosodimethylamine (“NDMA”).
NDMA has been the subject of a large variety of studies that have positively identified a link between this ingredient in Zantac and cancers. There is also a good deal of evidence that Sanofi and Boehringer Ingelheim, the major pharma- companies who produced ranitidine hydrochloride, better known as Zantac, concealed the link between their product and the potential for cancer.
As a result, millions of people inadvertently took the pharmaceutical for a variety of conditions including gastric and duodenal ulcers, heartburn, sour stomach, gastroesophageal reflux disease (GERD), Barrett’s esophagus, acid reflux, and many other conditions. This simple concealment allowed Sanofi and Boehringer Ingelheim, to accrue a fortune of $1Billion from the sales of Zantac –– the first drug ever to generate this figure.
Many people have fallen sick with cancer after taking this carcinogenic pharmaceutical and the only recourse for the justice they have are the courts and a Zantac lawsuit that can make Sanofi and Boehringer Ingelheim accountable for their egregious misdeeds and reckless endangerment in the pursuit of profits.
What is Zantac?
Ranitidine, also known as Zantac, is a pharmaceutical designed to reduce the production of acids in the stomach. This has prescribed extensively for treating stomach and intestinal ulcers, Zollinger-Ellison syndrome, peptic ulcers, indigestion, and heartburn.
Zantac can also be obtained over the counter with the primary purpose being the treatment of heartburn. The prescription medication was often used for treating ulcers and other digestive conditions. This drug was first placed on the market in 1981 and has become the 50th most commonly prescribed medication in the United States
Has the FDA Issued Any Warnings on Zantac?
The US FDA issued a warning on the 13th of September, 2019, after finding that Zantac contained a carcinogenic compound NDMA, which is actually the active ingredient in NDMA. The levels of this carcinogenic compound were between 3,000 and 26,000 times the standards approved by the FDA.
The FDA has recommended a limit to daily intake below 100 nanograms. A single 150 mg pill of Zantac can contain up to 2.5 million nanograms of NDMA, The size of a regular OTC Zantac pill is 150mg, while the prescription version can be up to 300mg and be taken each night for up to eight weeks.
Plaintiff’s claim that Sanofi and Boehringer Inglham were fully aware of the risks involved with NDMA in ranitidine and still did nothing to alert the public and the medical community to the danger of this drug. Studies have been published that show that those who have consumed Zantac have concentrations of NDMA in their urine equal to 400 times what they would have been had they not taken the drug. Studies also show that consumers would not have taken the drug if they had been properly informed of the risks.
Has Zantac Been Found to Cause Cancer?
NDMA has been found highly toxic to the cells of the liver and prolonged exposure can result in a variety of symptoms including cancer of the stomach and bladder, liver fibrosis, liver scarring, as well as tumors of the kidneys, lungs, and liver. The World Health Organization has described NDMA as a clearly carcinogenic chemical.
Presently, the FDA is working with industry partners and regulators to ascertain the source of the impurities in Zantac. Through a careful study of ranitidine, the FDA will be able to assess the risk it poses to patients. This will be an ongoing investigation and will lead to the appropriate measures being taken.
Has Zantac Been Recalled?
As yet, the FDA has not called for a full stop to ranitidine use and has not called the manufacturer to recall the product. However, some of the major companies that sell Zantac have suspended sales until more information can be learned from ongoing tests and research.
At this moment, it doesn’t seem that Zantac contains enough NDMA to actually cause cancer in a human. Nevertheless, NDMA has been classified as a potential carcinogen and it is possible that if the exposure has been in high doses for a long time, cancer is a likely result.
Understanding this, it is not recommended that Zantac be used for prolonged periods of time. The FDA recommends that those who do wish to discontinue use speak with their medical care professional about a healthier alternative. There is a wide range of other drugs available that can offer the same effects without the same NDMA exposure.
How is a Zantac Lawsuit Filed?
Because many people have been exposed to unsafe levels of NDMA, many class-action lawsuits have been filed. Those that have been diagnosed with stomach or bladder cancer after taking Zantac may be eligible for certain damages, including:
- Medical expenses resulting from injuries
- Wage loss, loss of earning capacity
- Loss of enjoyment of life resulting from damages
- Pain and suffering caused by the injuries, treatment, and recovery period.
- Punitive Damages
A successful class-action lawsuit will help those suffering the effects of prolonged exposure to NDMA. They may be able to recover the cash sent on treatment and medication to address the conditions that prolonged exposure may cause and other damages for the loss of wages, etc. Furthermore, these lawsuits will work to ensure more stringent consumer protection laws and proper product labeling.
Consumers and those in the medical community are always advised to report any ranitidine reactions to the MedWatch program. This keeps the agency notified of all potential hazards related to this potentially risky drug.
A Zantac lawsuit will be filed just as any other lawsuit would be filed for personal injury cases. It is therefore important to have a working knowledge of the process before beginning. It is invariably the most intelligent first move to retain the services of a reputable personal injury attorney with experience in handling drug litigation cases. If you have lost a loved one due to injuries sustained by exposure to Zantac, you will also need to have an expert on wrongful death apply their knowledge to the Zantac lawsuit.
Your Zantac personal injury attorney will help review your case and identify the parties who hold liability for your damages. You will need to begin gathering all the information you can as evidence against this guilty party. The evidence will help to establish the total amount of damages you suffered as a result of your injuries, also called the damages.
In cases like these, the injured party may also choose to sue for punitive damages and compensatory damages. Your qualified lawyer will be able to properly calculate the damages that were incurred and file the lawsuit that will demand compensation for damages incurred.
Contact an experienced Zantac Attorney at Schneider Hammers Today
If you have been injured or lost a loved one through the use of Zantac, call the law offices of Schneider and Hammers. We will offer a full consultation and review of your case for free and with no obligations at all. Furthermore, we will not charge you a thing for our time, skills and representation unless we win your case and get you’re the compensation your demand. Contact an Atlanta zantac lawyer today for more information.